Article Information
History
- September 18, 2019.
Article Versions
- Version 1 (January 16, 2019 - 08:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Paul C. Moore1,2,3,
- Jenny Y. Qi1,2,3,
- Maike Thamsen1,4,5,6,
- Rajarshi Ghosh1,4,5,6,
- Justin Peng1,2,3,
- Micah J. Gliedt4,5,
- Rosa Meza-Acevedo1,4,5,6,
- Rachel E. Warren1,2,3,
- Annie Hiniker1,2,3,
- Grace E. Kim1,2,
- Dustin J. Maly7,
- Bradley J. Backes4,5,
- Feroz R. Papa1,3,4,5,6,* and
- Scott A. Oakes1,2,3,8,9,*
- 1Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 3Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 4Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 5Lung Biology Center, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 6California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, CA 94143, U.S.A.
- 7Department of Chemistry, University of Washington, Seattle, WA 98195, U.S.A.
- 8Department of Pathology, Biological Sciences Division, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, U.S.A.
- ↵*Correspondence: feroz.papa{at}ucsf.edu, soakes{at}bsd.uchicago.edu
P. Moore and J. Qi contributed equally to this article
Posted September 18, 2019.
Parallel signaling through IRE1α and PERK regulates pancreatic neuroendocrine tumor growth and survival
